amgen maritide glp-1 drug comparison What to know about MariTide, Amgen's experimental MariTide: Amgen's Monthly GLP-1 Shot

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

What's the difference between Pepcid vs Prilosec

These blockbuster medications have been associated with a range of health benefits, but a lack of data about how the drugs impact adults age 65 and up has clini

These cost-saving results have implications for patients, physicians, insurers, and governments

The G in GLP-1 might as well stand for gold.